subscribeSubscribe
Eisai`s antiepileptic drug Fycompa injection formulation launches in Japan

Eisai`s antiepileptic drug Fycompa injection formulation launches in Japan
BIOSPECTRUM ASIA
18 Apr 2024
Share Share
Ligand Partner Eisai Receives Approval for Injection Formulation of Fycompa

Ligand Partner Eisai Receives Approval for Injection Formulation of Fycompa
BUSINESSWIRE
22 Feb 2024
Share Share
Catalyst Announces Multiple Abstracts on FYCOMPA from Eisai to be Presented

Catalyst Announces Multiple Abstracts on FYCOMPA from Eisai to be Presented
GLOBENEWSWIRE
14 Aug 2023
Share Share
Akums gets DCGI approval for Perampanel Oral Suspension

Akums gets DCGI approval for Perampanel Oral Suspension
EXPRESS PHARMA
27 Jun 2023
Share Share
Catalyst Announces Third-Party Abstracts on FYCOMPA® (Perampanel)

Catalyst Announces Third-Party Abstracts on FYCOMPA® (Perampanel)
GLOBENEWSWIRE
20 Apr 2023
Share Share
FDA Confirms Paragraph IV Patent Litigation for Perampanel Oral Suspension

FDA Confirms Paragraph IV Patent Litigation for Perampanel Oral Suspension
FDA
13 Feb 2023
Share Share
Catalyst Pharmaceuticals to buy US rights for Eisai’s Fycompa

Catalyst Pharmaceuticals to buy US rights for Eisai’s Fycompa
PHARMACEUTICAL-TECHNOLOGY
20 Dec 2022
Share Share
Catalyst Pharmaceuticals to buy US rights for Eisai’s Fycompa

Catalyst Pharmaceuticals to buy US rights for Eisai’s Fycompa
PHARMACEUTICAL-TECHNOLOGY
20 Dec 2022
Share Share
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA

Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA
GLOBENEWSWIRE
19 Dec 2022
Share Share
Teva Pharma Generic Perampanel Receives Tentative Approval in US

Teva Pharma Generic Perampanel Receives Tentative Approval in US
FDA
01 Jul 2022
Share Share